Grifols SA SEC filings GRFS
Grifols SA has 463 filings in SEC EDGAR's recent list, going back to Oct 20, 2008. Its latest annual report, Form 20-F, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Dec 29, 2017 | — |
| 424B3 | Prospectus | Apr 23, 2015 | — |
| F-4 | Filing | Apr 1, 2015 | — |
| F-3ASR | Filing | Apr 23, 2013 | — |
| 424B3 | Prospectus | Jul 23, 2012 | — |
| F-6EF | Filing | Jul 12, 2012 | — |
| 424B3 | Prospectus | Nov 9, 2011 | — |
| F-4 | Form f-4 | Oct 24, 2011 | — |
| F-6 | Filing | Mar 9, 2011 | — |
| 424B3 | Prospectus | Feb 24, 2011 | — |
| 424B3 | Prospectus | Jan 14, 2011 | — |
| F-4/A | Filing | Dec 20, 2010 | — |
| F-4/A | Filing | Nov 5, 2010 | — |
| F-4/A | Form f-4/a | Oct 4, 2010 | — |
| F-4 | Form f-4 | Aug 10, 2010 | — |
| F-6 | Filing | May 18, 2009 | — |
| F-6EF | Form f-6 | Oct 20, 2008 | — |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GRFS (Nasdaq), GIFLF (OTC), GIFOF (OTC), GIKLY (OTC)
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1438569
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.